Delong Liu

Universal CARs, universal T cells, and universal CAR T cells

Juanjuan Zhao, Quande Lin, Yongping Song, 2018, Journal of Hematology & Oncology.

Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application

Delong Liu, Byung Lee, Delong Liu, 2013, Biomarker Research.

MEK and the inhibitors: from bench to bedside

Delong Liu, Delong Liu, Muhammad Furqan, 2013, Journal of Hematology & Oncology.

Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis

Delong Liu, Byung Lee, Delong Liu, 2012, Experimental Hematology & Oncology.

Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways

Xianghua Lin, Delong Liu, Marietta Y. W. T. Lee, 2008, Journal of hematology & oncology.

Novel biomarkers for diagnosis, prognosis, targeted therapy and clinical trials

Hong Wang, Delong Liu, Hong Wang, 2013, Biomarker Research.

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

Delong Liu, Yue-hua Ma, Delong Liu, 2010, Journal of hematology & oncology.